PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Neuropsychiatry

Psychiatric Times. Vol. 25 No. 6
Pages: 1  2  
Previous
 

Neurotheology: Are We Hardwired for God?

By René J. Muller, PhD | May 1, 2008
Dr Muller formerly evaluated psychiatric patients in the emergency room at Union Memorial Hospital in Baltimore. He is the author, most recently, of Doing Psychiatry Wrong: A Critical and Prescriptive Look at a Faltering Profession, published by The Analytic Press/Taylor & Francis Group.


Having found a way to measure self-transcendence, Hamer's next step was to identify candidate genes that might influence people to be spiritual. He started with the observation that certain drugs altered consciousness toward self-transcendence and mysticism. Psilocybin, a hallucinogen derived from mushrooms, is known to induce mystical and sometimes religious states.10 Certain amphetamines, including ecstasy (3,4-methylenedioxymethamphetamine, MDMA), have well-documented hallucinogenic and mind-expanding properties. Hamer asked: Is there some chemical in the brain that is structurally similar to these drugs and that could endogenously promote transcendent experience?

Mind-altering drugs are thought to work primarily through receptors that bind monoamine ligands in the brain. Hamer looked at factors that would generally influence monoamine function in the drug-free brain, especially in the serotonin, dopamine(Drug information on dopamine), and noradrenaline neurotransmitter systems. After several false starts, Hamer had a chance meeting with George Uhl, MD, PhD, a neurobiologist at the National Institute of Drug Abuse, who studies generic vulnerability to substance abuse. Uhl had found some new variants in a gene called vesicular monoamine transporter 2 (VMAT2). This gene makes a protein for the vesicles that package neurotransmitters in the presynaptic neuron and later release these signaling chemicals into the neuronal synapse. He had sequenced the gene and mapped out a number of variants, including the polymorphism A33050C, located on chromosome 10. (In position 33050 of that chromosome, a person may have either A [adenine] or C [cytosine].) Uhl had shown that the VMAT2 polymorphism was highly associated with other VMAT2 mutations and could be used as a marker for the gene.

The fact that the protein made from the VMAT2 gene was involved in packaging all the monoamine neurotransmitters—Hamer's candidate endogenous molecules for self-transcendence and spirituality—made this gene a particularly attractive target for study. According to Hamer, "VMAT2 controls the flow of monoamines within the brain" and promotes a "higher consciousness."6 The packaging vesicles, besides delivering neurotransmitters to the synaptic cleft for signal transduction, protect these molecules from degradation by enzymes, particularly monoamine oxidases, which remove the neurotransmitter once the neuron fires and the signal has been sent.

Using a color-coded fluorescence assay for A33050C and a fast computer, Hamer compared his subjects' genotypes with their test scores on the Cloninger self-transcendence scale. "We hit pay dirt," is how Hamer described the result.

"There was a clear association between the VMAT2 polymorphism and self-transcendence. Individuals with a C in their DNA—on either one chromosome or both—scored significantly higher than those with an A... Somehow, this single-base change was affecting every facet of self-transcendence, from loving nature to loving God, from feeling at one with the universe to being willing to sacrifice for its improvement.
     The VMAT2 gene variant containing a C—or "spiritual allele," as I began to think of it—was present on only 28% of chromosomes, compared with 72% carrying an A. But because both the C/C and the C/A genotypes had increased self-transcendence scores, compared to the A/A genotype, it worked out that 47%... were in the higher spirituality group, as compared with 53% in the lower group. ...While this one gene might not make one a saint, a prophet, or a seer, it was enough to tip the spiritual scales and predispose one toward spirituality (pp 73-74)".

Though Hamer claims that the VMAT2 polymorphism holds the key to understanding spirituality, he never explains why the C/C genotype is better than the A/A genotype in packaging and protecting brain monoamines from enzymatic degradation and other adverse fates.

God's hardwiring not empirically demonstrated
In searching out the God gene, Hamer wanted to know if consciousness can be explained "scientifically."

"By a scientific explanation, I mean one that can be expressed in terms of the basic principles of chemistry and physics. Proponents of this view often are called 'materialists' because they believe that all mental processes can ultimately be accounted for by a few basic physical laws. Most scientists, including myself, are materialists (p 94)."

As a materialist, Hamer must maintain that believing in God involves some kind of brain "wiring." Though the word hardwired appears in the subtitle of The God Gene, near the end of the text he offers this qualification.

"[J]ust because spirituality is partly genetic doesn't mean it is hardwired. Our genes are more like a family recipe handed down by word of mouth than a precise set of instructions that must be followed in exact detail. The final product depends a lot on how you interpret and execute the formula (pp 211-212)."

Hamer's materialism goes off on a curious metaphorical course here, right into the kitchen! In spite of this epigenetic qualification of his genetic theory of spirituality, and his acknowledgment that besides VMAT2 there may be other God genes, Hamer pushes through to his conclusion. We could ask what standard in science is being met here, or, for that matter, what standard in theology?

And then there is this question: However one might be impressed by the correlation between the VMAT2 gene polymorphism and spirituality, a difference in the vesicular covering of monoamine neurotransmitters in the brain seems to be a pretty small variant on which to hang so important and universal a phenomenon as the capacity for spirituality. One wonders how many other theories could have been put forward and how many other experiments could have been performed that would have also yielded "positive" results.

The "bottom up" explanations for religious belief and spirituality offered by neurotheologians and neurogeneticists derive from a science that sees our lives as being largely determined by biological factors. These theories are based on empirical data that have been "stretched" across a discontinuity that still separates the constructs of brain and mind.11 In spite of what some clinicians and theoreticians propose, no one can yet say how the brain—which is necessary for all activity that we recognize as human and is clearly a progenitor of what we call the mind—produces the contents of consciousness,12 including religious belief.

Acknowledgement: The author thanks David L. Smith, CSSp, PhD. His article on neurotheology cited here was Dr Muller's introduction to the subject, and he drew heavily from it in writing the first section of this article.
 

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Blake Griffin | March 08, 2012 6:05 PM EST

hi





References
1. Neurotheology. Wikipedia. August 13, 2007. en. wikipedia.org/wiki/neurotheology. Accessed August 14, 2007.
2. Joseph R. The limbic system and the soul: evolution and the neuroanatomy of religious experience. Zygon. 2001;36:105-136.
3. Delio I. Are we wired for God? New Theol Rev. 2003; 16:31-43.
4. Smith DL. Does God slumber deep in the belly of the brain? A critique of neurotheology. Josephinum J Theol. 2006;13:81-99.
5. d'Aquili EG, Newberg AB. Religious and mystical states: a neuropsychological model. Zygon. 1993;28: 177-200.
6. Hamer D. The God Gene: How Faith Is Hardwired Into Our Genes. New York: Doubleday; 2004.
7. Kluger J. Is God in our genes? Time. 2004;164:62-70.
8. Sabol SZ, Nelson ML, Fisher C, et al. A genetic association for cigarette smoking behavior. Health Psychol. 1999;18:7-13.
9. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975-990.
10. Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial sustained personal meaning and spiritual significance. Psychopharmacology. 2006;187:268-283.
11. Ellis RD. Phenomenology-friendly neuroscience: the return to Merleau-Ponty as psychologist. Hum Stud. 2006;29:33-55.
12. McHugh PR, Slavney PR. The Perspectives of Psychiatry. 2nd ed. Baltimore: The Johns Hopkins University Press; 1998:11-13.


 
RELATED TOPICS

Amnesia
Cognitive disorders
Delirium
Early onset Alzheimer disease
Neuropsychiatry


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • The Moral Struggles of Practicing Psychiatrists
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Journey of the Traumatized Hero: Kerouac’s On the Road and Gandhi’s Railroad Ride
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
  • New Insight Into the Neurobiology of Depression
  • Cultural Psychiatry and the 'No-Chicken' Doctor
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
CME
Get CME for reading Psychiatric Times articles
Mood Disorders
Anxiety Disorders
Sleep Disorders
Psychopharmacology
Schizophrenia-Psychotic disorders
Cognitive Disorders
Substance Abuse
Medical Comorbidities
More Psychiatry CME


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Neuropsychiatry
Evidence on Neuropsychiatry
Guidelines on Neuropsychiatry
Patient Education on Neuropsychiatry
Clinical Trials on Neuropsychiatry
Practical Articles on Neuropsychiatry
Research and Reviews on Neuropsychiatry
All "Neuropsychiatry" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy